Friday, 16 October 2026European Markets

SANDNES SPAREBANK, ABC ARBITRAGE, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - sandnes sparebank (sadg.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
sandnes sparebank (sadg.ol) kr87.00 6.91% 8.23%
abc arbitrage (abca.pa) €6.03 6.06% 17.35%
sparebank 1 sr-bk (srbnk.ol) kr120.00 5.85% 12.05%
sparebanken møre (morg.ol) kr77.11 5.13% 9.92%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sandnes sparebank (sadg.ol)

6.91% forward dividend yield and 8.23% return on equity

sandnes sparebank, an independent savings bank, provides a range of banking and investment products to retail and corporate customers in norway. it operates through three segments: retail market, corporate market, and real estate. the company offers fixed rate deposits, deposit accounts, bsu, and tax withholding and other accounts; child, death, income, critical illness, disability, car, home, cabin, contents, ung, and other insurance products; and pension solutions. it also provides bank guarantee, overdrafts, leasing, construction and business loans, factoring and invoice sales; fixed interest, mortgage, car, and other vehicle loans, as well as small loans and refinancing, and green loans; bank and credit cards; various loans and guarantees; and mobile and internet banking services. in addition, the company offers real estate brokerage and general investment advisory services. sandnes sparebank was founded in 1875 and is headquartered in sandnes, norway.

earnings per share

as for profitability, sandnes sparebank has a trailing twelve months eps of kr8.1.

pe ratio

sandnes sparebank has a trailing twelve months price to earnings ratio of 10.74. meaning, the purchaser of the share is investing kr10.74 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.23%.

more news about sandnes sparebank.

2. abc arbitrage (abca.pa)

6.06% forward dividend yield and 17.35% return on equity

abc arbitrage sa, together with its subsidiaries, develops arbitrage strategies for liquid assets worldwide. it develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. the company was incorporated in 1995 and is based in paris, france.

earnings per share

as for profitability, abc arbitrage has a trailing twelve months eps of €0.49.

pe ratio

abc arbitrage has a trailing twelve months price to earnings ratio of 12.31. meaning, the purchaser of the share is investing €12.31 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.35%.

more news about abc arbitrage.

3. sparebank 1 sr-bk (srbnk.ol)

5.85% forward dividend yield and 12.05% return on equity

sparebank 1 sr-bank asa, together with its subsidiaries, provides various financial products and services for personal and corporate customers in southern and western norway. it offers its products and services in the areas of savings, loans, insurance, and pensions. the company also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, estate agency, payroll/hr, securities trading, and investments services; green loans; credit and debit cards; consulting; and banking services. in addition, it facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. further, the company is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. it also serves retail and corporate, small business, and agricultural customers, as well as the public sector. the company was founded in 1839 and is headquartered in stavanger, norway.

earnings per share

as for profitability, sparebank 1 sr-bk has a trailing twelve months eps of kr12.88.

pe ratio

sparebank 1 sr-bk has a trailing twelve months price to earnings ratio of 9.32. meaning, the purchaser of the share is investing kr9.32 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.

more news about sparebank 1 sr-bk.

4. sparebanken møre (morg.ol)

5.13% forward dividend yield and 9.92% return on equity

sparebanken møre, together with its subsidiaries, provides banking services for retail and corporate customers primarily in møre og romsdal, norway. it operates through corporate, retail, and real estate brokerage segments. the company offers services in the areas of funding, deposits and other forms of investments, asset management, financial advisory, money transfer, currency and interest rate trading, insurance, and real estate brokerage. sparebanken møre was founded in 1843 and is headquartered in ålesund, norway.

earnings per share

as for profitability, sparebanken møre has a trailing twelve months eps of kr15.13.

pe ratio

sparebanken møre has a trailing twelve months price to earnings ratio of 5.1. meaning, the purchaser of the share is investing kr5.1 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.92%.

growth estimates quarters

the company's growth estimates for the current quarter is a negative 70.6% and positive 32.6% for the next.

more news about sparebanken møre.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com